NCT01250639

Brief Summary

This study is a cooperative project and aims to identify genetic components associated with type 2 diabetes mellitus (T2DM), which is significant for the population of non-aboriginal Taiwanese.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 29, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 1, 2010

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

December 1, 2010

Status Verified

November 1, 2010

Enrollment Period

3.3 years

First QC Date

November 29, 2010

Last Update Submit

November 30, 2010

Conditions

Type 2 Diabetes Mellitus

Keywords

Type 2 Diabetes Mellitusnon-aboriginal TaiwaneseGenome-wide association study

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Type 2 Diabetes Mellitus

You may qualify if:

  • Age ≥ 20 years
  • Subject must satisfy the diagnostic criteria for T2D at the time of examination.
  • Subject is willing to participate and capable of giving informed consent.
  • Subject is a self reported non-aboriginal Taiwanese, and none of the parents and grand-parents has aboriginal background.
  • Relatives of T2DM subjects with a positive family history are willing to participate and capable of giving informed consent.

You may not qualify if:

  • Type 1 Diabetes
  • Gestational Diabetes
  • Monogenic Diabetes
  • Subject is unable to understand or give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital

Taichung, Taiwan, 40447, Taiwan

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

serum,urine

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Fuu-Jen Tsai, PHD

    Division of Metabolism and Endocrinology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fuu-Jen Tsai, PHD

CONTACT

866-4-22052121yhliang@mail.cmuh.org.tw

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 29, 2010

First Posted

December 1, 2010

Study Start

August 1, 2010

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

December 1, 2010

Record last verified: 2010-11

Locations

TW(1)